$SRZN 8-K SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Results of Operations and Financial Condition; Unregistered Sales of Equity Securities Proceeds strengthen balance sheet and provide expected cash runway into 2029 to advance SZN-8141 and SZN-8143
02 Oct 2026	8-K: Other Events On October 2, 2026, Surrozen, Inc. (Surrozen) announced U.S. Food and Drug Administration (FDA) clearance of our Investigational New Drug (IND) application for SZN-8141, enabling us to advance the program into clinical development. The I...
06 Aug 2026	8-K: Results of Operations and Financial Condition
14 May 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
23 Mar 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
07 Nov 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
17 Oct 2025	8-K: Termination of a Material Definitive Agreement
29 Aug 2025	8-K: Entry into a Material Definitive Agreement
08 Aug 2025	8-K: Results of Operations and Financial Condition
15 May 2025	8-K: Submission of Matters to a Vote of Security Holders
09 May 2025	8-K: Results of Operations and Financial Condition
31 Mar 2025	8-K: Results of Operations and Financial Condition
28 Mar 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
24 Mar 2025	8-K: Regulation FD Disclosure
06 Nov 2024	8-K: Results of Operations and Financial Condition
02 Oct 2024	8-K: Entry into a Material Definitive Agreement
12 Aug 2024	8-K: Results of Operations and Financial Condition
01 Jul 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments